POC Molecular System
Accurate/ Accesible/ Actionable
diagnosis for better healthcare
What We Do
We design, manufacture and commercialize next generation molecular diagnostic tests, bringing the superior diagnostics performance of PCR to the point-of-care (POC).
We strive to bring DNA and RNA testing to a much larger population segment than alternative, legacy solutions so healthcare providers can more effectively treat patients.
Our proprietary OSCAR technology is key to our patented and patent-pending diagnostic solutions. Our revolutionary technology offers the simplicity, convenience and procedural familiarity of traditional POC rapid immunoassays while providing the superior sensitivity, specificity of laboratory-based molecular testing.
The PCR test technology developed by Mesa Biotech enables healthcare professionals to access actionable, laboratory-quality results at the Point of Care:
Mesa Biotech’s Accula System consists of a portable, palm-sized dock and assay-specific test cassettes
Superior diagnostics performance of nucleic acid PCR
Near patient results to start effective treatment
Accula FluA/B and Accula RSV are CE Marked, 510 (K) cleared and CLIA Waived